Hsien-hui T. Chung

Pingtung, TNQ 90710, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Metabolic Concepts of Sodium-Glucose Cotransporter 2 Inhibitors-Based Therapies Against Hepatocarcinogenesis and Therapy Resistance in Hepatocellular Carcinoma.

Metabolic Concepts of Sodium-Glucose Cotransporter 2 Inhibitors-Based Therapies Against Hepatocarcinogenesis and Therapy Resistance in Hepatocellular Carcinoma.

Journal: Life (Basel, Switzerland)

Published: January 24, 2026

The multifaceted modulations by dapagliflozin in preventing hyperglycemia-induced diabetic nephropathy through glucose transporters and PPARα.

The multifaceted modulations by dapagliflozin in preventing hyperglycemia-induced diabetic nephropathy through glucose transporters and PPARα.

Journal: Journal of diabetes and metabolic disorders

Published: April 05, 2025

The dysregulation of high glucose-induced iPSC-neural stem cells differentiation by caspase-1.

The dysregulation of high glucose-induced iPSC-neural stem cells differentiation by caspase-1.

Journal: Neuroscience letters

Published: March 11, 2025

IPSC-Derived Conditioned Medium Reduces Oxidative Stress and Vascular Remodeling in Rat Models of Pulmonary Arterial Hypertension.

IPSC-Derived Conditioned Medium Reduces Oxidative Stress and Vascular Remodeling in Rat Models of Pulmonary Arterial Hypertension.

Journal: Journal of cellular physiology

Published: March 06, 2025

Pharmacological Modulation of Mutant TP53 with Oncotargets Against Esophageal Cancer and Therapy Resistance.

Pharmacological Modulation of Mutant TP53 with Oncotargets Against Esophageal Cancer and Therapy Resistance.

Journal: Biomedicines

Published: January 02, 2025

The liver-specific diagnosis and prognosis of fibrotic NASH through modulating fibroblast growth factor 21.

The liver-specific diagnosis and prognosis of fibrotic NASH through modulating fibroblast growth factor 21.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: January 19, 2024

Integrative prediction of metabolic dysfunction-associated fatty liver disease by endogenous fructose and related metabolism.

Integrative prediction of metabolic dysfunction-associated fatty liver disease by endogenous fructose and related metabolism.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: August 14, 2023

Enhanced muscle function in cause-specific mortality among patients with NAFLD-related sarcopenia.

Enhanced muscle function in cause-specific mortality among patients with NAFLD-related sarcopenia.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 29, 2023

The metabolic evaluation of pemafibrate in nonalcoholic fatty liver disease-related cardiovascular diseases.

The metabolic evaluation of pemafibrate in nonalcoholic fatty liver disease-related cardiovascular diseases.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: March 29, 2023

Letter to the Editor: The pathological impact of PAR2 on hepatic insulin resistance.

Letter to the Editor: The pathological impact of PAR2 on hepatic insulin resistance.

Journal: Hepatology (Baltimore, Md.)

Published: November 23, 2022

Evaluating the pharmacotherapy of tirzepatide in patients with type 2 diabetes: The consideration of systemic metabolism.

Evaluating the pharmacotherapy of tirzepatide in patients with type 2 diabetes: The consideration of systemic metabolism.

Journal: British journal of clinical pharmacology

Published: August 17, 2022

Letter to the editor: The perspective of GLP-1/GLP-2 receptors against NASH via diverse regulation.

Letter to the editor: The perspective of GLP-1/GLP-2 receptors against NASH via diverse regulation.

Journal: Hepatology (Baltimore, Md.)

Published: June 08, 2022

Showing 1-12 of 35

Last Updated: 09/26/2026